Intratumoral lymphatic vessels: A case of mistaken identity or malfunction?

Journal of the National Cancer Institute

Volumn 94, Issue 6, 2002, Pages 417-421

  Jain, Rakesh K ^a   Fenton, Brenda T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; BETA CHEMOKINE; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR; GROWTH FACTOR; HOMEODOMAIN PROTEIN; HYALURONIC ACID; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; CANCER CELL; CANCER INVASION; CANCER MORTALITY; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPH VESSEL; MECHANICAL STRESS; METABOLIC DISORDER; MORBIDITY; MOUSE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0037139527     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.6.417     Document Type: Note

References (60)

1. Extracellular compartments of solid tumors
2. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
3. Lymphatic vessels as targets for tumor therapy?
4. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
5. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
6. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis
7. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
8. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
9. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-Receptor 2 and host VEGF-A
10. Vascular-specific growth factors and blood vessel formation
11. A model for gene therapy of human hereditary lymphedema
12. Angiogenesis in cancer and other diseases
13. Identification of an angiogenic mitogen selective for endocrine gland endothelium
14. Circulating endothelial precursors: Mystery, reality, and promise
15. Barriers to drug delivery in solid tumors
16. Solid stress inhibits the growth of multicellular tumor spheroids
17. Local mechanics and VEGF-C alter peri-tumor lymphatic function
18. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
19. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3 in fenestrated blood vessels in human tissues
20. VEGFR-3 in adult angiogenesis
21. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
22. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages
23. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
24. Lymphatic endothelial and smooth-muscle cells in tissue culture
25. Lymphatic endothelial cell line (CH3) from a recurrent retroperitoneal lymphangioma
26. Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells
27. LYVE-1, the lymphatic system and tumor lymphangiogenesis
28. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
29. LYVE-1 is not restricted to the lymph vessels: Expression in normal liver blood sinusoids and downregulation in human liver cancer and cirrhosis
30. Prox1 function is required for the development of the murine lymphatic system
31. Active interaction of human A375 melanoma cells with the lymphatics in vivo
32. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination
33. Intratumoral infusion of fluid: Estimation of hydraulic conductivity and implications for the delivery of therapeutic agents
34. Transport in lymphatic capillaries: I. Macroscopic measurements using residence time distribution theory
35. Transport in lymphatic capillaries: II. Microscopic velocity measurement with fluorescence recovery after photobleaching
36. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
37. High-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions
38. Molecular, anatomical and functional dissection of tumors using intravital microscopy
39. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
40. Expression of angiogenic factors and tumor progression in human neuroblastoma
41. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis
42. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
43. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
44. Increased vascular endothelial growth factor-C and decreased nm23 expression associated with microdissemination in lymph nodes in stage I non-small cell lung cancer
45. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
46. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
47. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
48. VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression
49. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas
50. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
51. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma
52. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma
53. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer
54. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer
55. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers
56. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer
57. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer
58. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
59. Angiogenesis and lymphangiogenesis in stage I germ cell tumours of the testis
60. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma